Oesophageal cancer
Oesophageal cancer is the sixth most common cause of cancer-related death worldwide
and is therefore a major global health challenge. The two major subtypes of oesophageal …
and is therefore a major global health challenge. The two major subtypes of oesophageal …
Esophageal cancer
PC Enzinger, RJ Mayer - New England Journal of Medicine, 2003 - Mass Medical Soc
Cancers arising from the esophagus, including the gastroesophageal junction, are relatively
uncommon in the United States—the lifetime risk of this cancer is 0.8 percent for men and …
uncommon in the United States—the lifetime risk of this cancer is 0.8 percent for men and …
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
Oesophageal cancer is the seventh most common cancer worldwide, with 604 000 new
cases diagnosed in 2020. It is the sixth most common cause of cancer-related mortality, with …
cases diagnosed in 2020. It is the sixth most common cause of cancer-related mortality, with …
AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice
TW Rice, DT Patil… - Annals of cardiothoracic …, 2017 - pmc.ncbi.nlm.nih.gov
The 8th edition of the American Joint Committee on Cancer (AJCC) staging of epithelial
cancers of the esophagus and esophagogastric junction (EGJ) presents separate …
cancers of the esophagus and esophagogastric junction (EGJ) presents separate …
Esophageal and esophagogastric junction cancers, version 1.2015
JA Ajani, TA D'Amico, K Almhanna, DJ Bentrem… - Journal of the National …, 2015 - jnccn.org
Esophageal cancer is the sixth most common cause of cancer deaths worldwide.
Adenocarcinoma is more common in North America and Western European countries …
Adenocarcinoma is more common in North America and Western European countries …
18F-FDG PET/CT Imaging In Oncology
A Almuhaideb, N Papathanasiou… - Annals of Saudi …, 2011 - annsaudimed.net
Accurate diagnosis and staging are essential for the optimal management of cancer
patients. Positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-D-glucose …
patients. Positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-D-glucose …
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial
T Crosby, CN Hurt, S Falk, S Gollins… - The lancet …, 2013 - thelancet.com
Background Definitive chemoradiotherapy (CRT) is an alternative to surgery for the curative
treatment of oesophageal carcinoma. The SCOPE1 trial aimed to investigate the addition of …
treatment of oesophageal carcinoma. The SCOPE1 trial aimed to investigate the addition of …
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
Background Resection remains the best treatment for carcinoma of the oesophagus in terms
of local control, but local recurrence and distant metastasis remain an issue after surgery …
of local control, but local recurrence and distant metastasis remain an issue after surgery …
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
GJ Kelloff, JM Hoffman, B Johnson, HI Scher… - Clinical Cancer …, 2005 - aacrjournals.org
[18F] Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assesses a
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …
fundamental property of neoplasia, the Warburg effect. This molecular imaging technique …
Staging investigations for oesophageal cancer: a meta-analysis
EPM Van Vliet, MH Heijenbrok-Kal… - British journal of …, 2008 - nature.com
The aim of the study was to compare the diagnostic performance of endoscopic
ultrasonography (EUS), computed tomography (CT), and 18 F-fluoro-2-deoxy-D-glucose …
ultrasonography (EUS), computed tomography (CT), and 18 F-fluoro-2-deoxy-D-glucose …